Clindamycin phosphate and Dermatitis acneiform - a phase IV clinical study of FDA data

Summary:

Dermatitis acneiform is reported as a side effect among people who take Clindamycin phosphate (clindamycin phosphate), especially for people who are female, 50-59 old, also take Tarceva, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Dermatitis acneiform when taking Clindamycin phosphate. It is created by eHealthMe based on reports of 3,863 people who have side effects when taking Clindamycin phosphate from the FDA, and is updated regularly.

What is Clindamycin phosphate?

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.

What is Dermatitis acneiform?

Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis) is found to be associated with 483 drugs and 493 conditions by eHealthMe. Check the latest studies of Dermatitis acneiform.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

3,863 people reported to have side effects when taking Clindamycin phosphate.
Among them, 15 people (0.39%) have Dermatitis acneiform.

Could Clindamycin phosphate cause Dermatitis acneiform?

Among these 15 people:

What is the gender of people who have Dermatitis acneiform when taking Clindamycin phosphate? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Dermatitis acneiform when taking Clindamycin phosphate? *

What are other drugs people take besides Clindamycin phosphate? *

What are other side effects people have besides Dermatitis acneiform? *

Fatigue (feeling of tiredness): 5 people, 33.33%
Rashes (redness): 5 people, 33.33%
Back Pain: 3 people, 20.00%
Rhinorrhea (watery mucus discharge from the nose): 3 people, 20.00%
Drug Ineffective: 3 people, 20.00%
Malignant Neoplasm Progression (cancer tumour came back): 2 people, 13.33%
Pain In Extremity: 2 people, 13.33%
Osteoporosis (bones weak and more likely to break): 2 people, 13.33%
Metastases To Spine (cancer spreads to spine): 2 people, 13.33%
Metastases To Liver (cancer spreads to liver): 2 people, 13.33%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 40.00%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 20.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 13.33%
Metastases To Liver (cancer spreads to liver): 2 people, 13.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 6.67%
Metastases To Bone (cancer spreads to bone): 1 person, 6.67%
Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 6.67%
Hidradenitis (chronic disease of a type of sweat gland): 1 person, 6.67%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clindamycin phosphate and have Dermatitis acneiform?

- Check whether Dermatitis acneiform is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clindamycin phosphate:

Clindamycin phosphate (4,216 reports)

Browse all side effects of Clindamycin phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis acneiform:

Dermatitis acneiform (483 drugs)

Browse all the conditions that are associated with Dermatitis acneiform:

Dermatitis acneiform (493 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate (the active ingredients of Clindamycin phosphate) and Clindamycin phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.